A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
D000328:Adult; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000378:metabolism*; D001792:Blood Platelets / Q000187:drug effects*; D003018:Clot Retraction; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D009640:Norethindrone / Q000494:pharmacology*; D010298:Parity; D010973:Platelet Adhesiveness / Q000187:drug effects; D011516:Prothrombin / Q000032:analysis; D013997:Time Factors
D001779:Blood Coagulation Factors; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005170:Factor X; D005340:Fibrinogen; D009640:Norethindrone